Literature DB >> 34320132

Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil.

Nelson Pereira Marques1, Nádia Carolina Teixeira Marques2,3, Iberto Medeiros Cardozo4, Daniella Reis Barbosa Martelli5, Edson Gomes de Lucena6, Eduardo Araújo Oliveira7,8, Hercílio Martelli Júnior2,5.   

Abstract

INTRODUCTION: Coronavirus disease 2019 (COVID-19) has limited the access of patients with Hansen's disease (HD) to care due to changes in routine health services.
METHODS: To ascertain this, we compared the number of HD cases diagnosed before and after the COVID-19 pandemic.
RESULTS: The decrease in HD cases in Brazil reached 18,223 (-48.4%), corresponding to an average reduction of 1,518 cases per month during the COVID-19 pandemic.
CONCLUSION: Therefore, effective measures should be implemented to minimize the damage and the consequent negative health impact of COVID-19 on the care of HD patients.

Entities:  

Mesh:

Year:  2021        PMID: 34320132     DOI: 10.1590/0037-8682-0251-2021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  The state of the leprosy epidemic in Yunnan, China 2011-2020: A spatial and spatiotemporal analysis, highlighting areas for intervention.

Authors:  Xiaohua Chen; Tie-Jun Shui
Journal:  PLoS Negl Trop Dis       Date:  2021-10-06

2.  Design and Evaluation of a Smartphone Medical Guidance App for Outpatients of Large-Scale Medical Institutions: Retrospective Observational Study.

Authors:  Kei Teramoto; Shigeki Kuwata
Journal:  JMIR Form Res       Date:  2022-04-21

3.  Hansen's disease and COVID-19 co-infection in Brazil.

Authors:  Taynah Alves Rocha Repsold; Simon M Collin; Raquel Carvalho Bouth; Selma Regina Penha Silva Cerqueira; Marisa Simon Brezinscki; Rebeca Ruppert Galarda Baptista Peixoto; Andrea Maia Fernandes de Araújo Fonseca; Marlene Leandro Dos Santos Peixoto; Seyna Rabelo Mendes; Ciro Martins Gomes; Claudio Guedes Salgado; Patrícia D Deps
Journal:  Int J Dermatol       Date:  2022-07-01       Impact factor: 3.204

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.